Form 8-K - Current report:
SEC Accession No. 0001104659-21-054639
Filing Date
2021-04-26
Accepted
2021-04-26 06:05:48
Documents
18
Period of Report
2021-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114011d1_8k.htm   iXBRL 8-K 34826
2 EXHIBIT 4.1 tm2114011d1_ex4-1.htm EX-4.1 93596
3 EXHIBIT 10.1 tm2114011d1_ex10-1.htm EX-10.1 194417
4 EXHIBIT 10.2 tm2114011d1_ex10-2.htm EX-10.2 63451
5 EXHIBIT 99.1 tm2114011d1_ex99-1.htm EX-99.1 11473
9 GRAPHIC tm2114011d1_ex10-2img001.jpg GRAPHIC 7700
10 GRAPHIC tm2114011d1_ex99-1img001.jpg GRAPHIC 5494
  Complete submission text file 0001104659-21-054639.txt   684882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20210426.xsd EX-101.SCH 3187
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20210426_lab.xml EX-101.LAB 34592
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20210426_pre.xml EX-101.PRE 22711
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2114011d1_8k_htm.xml XML 3602
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 21851433
SIC: 2834 Pharmaceutical Preparations